Research Article

Relationship between Fetuin-A and vascular or valvular calcification in hemodialysis patients

Shahrzad Ossareh*, Bahareh Marghoob and Robabeh Bayat

Published: 07 January, 2019 | Volume 3 - Issue 1 | Pages: 001-011

Purpose: Deficiency of Fetuin A, as a calcification inhibitor, is assumed to be involved in vascular calcification in patients on maintenance hemodialysis (MHD). This study examined the relationship between serum Fetuin-A and vascular and valvular calcification in a cohort of MHD patients.

Methods: The study was conducted on 122 MHD patients. Serum levels of calcium, phosphorus, parathormone, and Fetuin-A were tested. Intima-media thickness (IMT) ≥0.8 mm and the presence of stenosis>50% or plaques in carotid doppler sonography were considered as vascular calcification. Calcification of cardiac valves or mitral annular calcification in two-dimensional echocardiography, were considered as cardiac valvular calcification. The presence of any or both of the two conditions was defined as cardiovascular calcification (CVC).

Results: Fetuin-A was lower than normal in 37% of 122. Totally 106 patients (87%) had CVC, who were older (61±14 vs. 38±14 years, P<0.001), more affected by diabetes (54% vs. 13%, P=0.007), had a longer dialysis vintage (median 5 vs. 2 years, P=0.006), lower levels of creatinine (8.9±2.8 vs. 11.9±3.1 mg/dL, P<0.001) and higher levels of calcium (8.7±0.7 vs. 8.4±0.5 mg/dL, P=0.026). There was no significant difference in mean Fetuin-A level between the two groups (P=0.101). In logistic regression increased age (OR=1.1, CI 95%=1.1 - 1.2) and serum calcium (OR=2.8, CI 95%=1.1- 7.6), and diabetes mellitus (OR=7.4, CI 95%=1.1 - 47.4) were risk factors.

Conclusion: This study showed that 87% of our patients had vascular and/or valvular calcification. Increased age and calcium level and diabetes were the predictors of CVC, whereas Fetuin-A was not.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001021 Cite this Article Read Full Article PDF


Cardiovascular calcification; Valvular calcification; Vascular calcification; Fetuin A; Hemodialysis


  1. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, et al. Excerpts From the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. 2010; 55: A6-A7. Ref.: https://goo.gl/s3HHAZ
  2. Efstratiadis G, Koskinas K, Pagourelias E. Coronary calcification in patients with end-stage renal disease: a novel endocrine disorder? Hormones (Athens). 2007; 6: 120-131. Ref.: https://goo.gl/grJQZZ
  3. Tomiyama C, Higa A, Dalboni MA, Cendoroglo M, Draibe SA, et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006; 21: 2464-2471. Ref.: https://goo.gl/wFiQwJ
  4. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005; 16: 529-538. Ref.: https://goo.gl/TvkUea
  5. Nitta K. Vascular calcification in patients with chronic kidney disease. Therapeutic Apheresis and Dialysis. 2011; 15: 513-521. Ref.: https://goo.gl/A4BtKv
  6. Shroff RC, Shanahan CM. The vascular biology of calcification. In, Seminars in dialysis: Wiley Online Library. 2007; 103-109. Ref.: https://goo.gl/Y3pWyw
  7. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, et al. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis. 1996; 27: 394-401. Ref.: https://goo.gl/wivqVu
  8. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009; 20: 1453-1464. Ref.: https://goo.gl/H6e9WD
  9. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification roles of phosphate and osteopontin. Circ Res. 2005; 96: 717-722. Ref.: https://goo.gl/qBocwq
  10. Ossareh S. Vascular calcification in chronic kidney disease: mechanisms and clinical implications. Iran J Kidney Dis. 2011; 5: 285-299. Ref.: https://goo.gl/r4F15a
  11. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, et al. Multifunctional Roles for Serum Protein Fetuin-A in Inhibition of Human Vascular Smooth Muscle Cell Calcification. J Am Soc Nephrol. 2005; 16: 2920-2930. Ref.: https://goo.gl/vU2GmJ
  12. Oikawa O, Higuchi T, Yamazaki T, Yamamoto C, Fukuda N, Matsumoto K. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol. 2007; 11: 304-308. Ref.: https://goo.gl/pM12u8
  13. Imel EA, Econs MJ. Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol. 2005; 16: 2565-2575. Ref.: https://goo.gl/NB8aFC
  14. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int. 2005; 67: 2383-2392. Ref.: https://goo.gl/2TZDFs
  15. Wang AYM, Woo J, Lam CWK, Wang M, Chan IHS, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005; 20: 1676-1685. Ref.: https://goo.gl/1KBGce
  16. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, et al. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006; 21: 1293-1299. Ref.: https://goo.gl/ZUXaZm
  17. Jung HH, Kim S-W, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant. 2006; 21: 1915-920. Ref.: https://goo.gl/piqZ9L
  18. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 2005; 67: 1070-1077. Ref.: https://goo.gl/9StwKn
  19. Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, et al. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int. 2003; 63: S84-S87. Ref.: https://goo.gl/BWBeuc
  20. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int. 2005; 67: 2295-2304. Ref.: https://goo.gl/Tpbca8
  21. Odamaki M, Shibata T, Takita T, Kumagai H. Serum fetuin-A and aortic calcification in hemodialysis patients. Kidney Int 2005; 68: 2915. Ref.: https://goo.gl/vKSPSF
  22. Ossareh S, Alaei A, Saedi D. Carotid intima-media thickness in maintenance hemodialysis patients: role of cardiovascular risk factor. Iran J Kidney Dis. 2011; 5: 169. Ref.: https://goo.gl/X2tzGM
  23. El-Shehaby AM, Zakaria A, El-Khatib M, Mostafa N. Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients. Scand J Clin Lab Invest. 2010; 70: 575-582. Ref.: https://goo.gl/EgRj3A
  24. Paul J, Shaw K, Dasgupta S, Ghosh MK. Measurement of intima media thichness of carotid artery by B-mode ultrasound in healthy people of India and Bangladesh, and relation of age and sex with carotid artery intima media thickness: : An observational study. J Cardiovasc Dis Res. 2012; 3: 128-131. Ref.: https://goo.gl/kxGNZ2
  25. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, et al. Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002; 39: 695-701. Ref.:
  26. Ribeiro S, Ramos A, Brandao A, Rebelo JR, Guerra A, Resina C, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998; 13: 2037-2040. Ref.: https://goo.gl/4cYR5a
  27. Rao AK, Djamali A, Korcarz CE, Aeschlimann SE, Wolff MR, et al. Mitral annular calcification is associated with reduced left ventricular function and inflammation in patients with chronic kidney disease. J Am Soc Echocardiogr. 2008; 2: 747-750. Ref.: https://goo.gl/NuLvWP
  28. Sayarlioglu H, Acar G, Sahin M, Altunoren O, Yavuz YC, et al. Prevalence and risk factors of valvular calcification in hemodialysis patients. Iran J Kidney Dis. 2013; 7: 129-134. Ref.: https://goo.gl/hTxQVP
  29. Mazzaferro S, Coen G, Bandini S, Borgatti P, Ciaccheri M, et al. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant. 1993; 8: 335-340. Ref.: https://goo.gl/UGXUvR
  30. Raggi P, Bellasi A, Gamboa C, Ferramosca E, Ratti C, et al. All-cause mortality in hemodialysis patients with heart valve calcification. Clinical J Am Soc Nephrol. 2011; 6: 1990-1995. Ref.: https://goo.gl/NXHvCy
  31. Wang C, Jiang L, Feng S, Shi Y, Shen H, et al. Risk factor analysis of calcification in aortic and mitral valves in maintenance peritoneal dialysis patients. Kidney and Blood Pressure Research. 2013; 37: 488-4895. Ref.: https://goo.gl/S8Wz5y
  32. Nemcsik J, Kiss I, Tislér A. Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease. World J Nephrol. 2012; 1: 25-34. Ref.: https://goo.gl/3gQzyD
  33. Tarrass F, Benjelloun M, Zamd M, Medkouri G, Hachim K, et al. Heart valve calcifications in patients with end‐stage renal disease: Analysis for risk factors. Nephrology. 2006; 11: 494-496. Ref.: https://goo.gl/6M6tBq
  34. Wang AYM, Ho SSY, Wang M, Liu EKH, Ho S, et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med. 2005; 165: 327-332. Ref.: https://goo.gl/e9wJ6S
  35. London GM, Marchais SJ, Guérin AP, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens. 2005; 14: 525-531. Ref.: https://goo.gl/Pc64vj
  36. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004; 95: 560-567. Ref.: https://goo.gl/nXJTWn
  37. Lee CT, Chua S, Hsu CY, Tsai YC, Ng HY, et al. Biomarkers Associated with Vascular and Valvular Calcification in Chronic Hemodialysis Patients. Dis Markers. 2013; 34: 229-235. Ref.: https://goo.gl/xBfk3d
  38. Abdel-Wahab AF, Fathy O, Al-Harizy R. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis. Arab J Nephrol Transplant. 2013; 6: 11-20. Ref.: https://goo.gl/WQZuGM
  39. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, et al. Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant. 2010; 25: 4041-4048. Ref.: https://goo.gl/wQE9Ub
  40. Jung HH, Baek HJ, Kim SW. Fetuin-A, coronary artery calcification and outcome in maintenance hemodialysis patients. Clin Nephrol. 2011; 75: 391-396. Ref.: https://goo.gl/TxvHe4
  41. Pencak P, Czerwieńska B, Ficek R, Wyskida K, Kujawa-Szewieczek A, et al. Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 2013; 14: 10. Ref.: https://goo.gl/ujA4Yj
  42. Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, et al. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease. Nephron Clin Pract. 2008; 108: c233-c240. Ref.: https://goo.gl/cZnpQn
  43. Hermans MMH, Kooman JP, Brandenburg V, Ketteler M, Damoiseaux JGMC, et al. Spatial inhomogeneity of common carotid artery intima-media is increased in dialysis patients. Nephrol Dial Transplant. 2007; 22: 1205-1212. Ref.: https://goo.gl/rMm6LY
  44. Ziolkowska H, Brzewski M, Roszkowska-Blaim M. Determinants of the intima–media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol. 2008; 23: 805-811. Ref.: https://goo.gl/bA7NeE
  45. Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, et al. Serum Fetuin A in Hemodialysis: A Link Between Derangement of Calcium-Phosphorus Homeostasis and Progression of Atherosclerosis? Am J Kidney Dis. 2009; 53: 467-474. Ref.: https://goo.gl/H3vWmF
  46. Pateinakis P, Papagianni A, Douma S, Efstratiadis G, Memmos D. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. BMC Nephrology. 2013; 14: 122. Ref.: https://goo.gl/nBQC6S
  47. Mann A, Makkar V, Mann S, Dhamija P, Soundarajan P. Fetuin-A and vascular calcification in Indian end-stage renal disease population. Indian J Nephrol. 2016; 26: 33-38. Ref.: https://goo.gl/ABCFKn
  48. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol. 2010; 21: 1998-2007. Ref.: https://goo.gl/Ds2bTp
  49. Liabeuf S, Okazaki H, Desjardins L, Fliser D, Goldsmith D, Covic A, et al. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? Nephrol Dial Transplant. 2014; 29: 1275-1284. Ref.: https://goo.gl/DfozG2
  50. Brix JM, Stingl H, Höllerl F, Schernthaner GH, Kopp HP, et al. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010; 95: 4877-4881. Ref.: https://goo.gl/HkqXKP
  51. Ghorbanihaghjo A, Argani H, Samadi N, Valizadeh S, Halajzadeh J, et al. Relationship Between Vitamin D Receptor Gene FokI and ApaI Polymorphisms and Serum Levels of Fetuin-A, Vitamin D, and Parathyroid Hormone in Patients on Hemodialysis. Iran J Kidney Dis. 2014; 8: 394-400. Ref.: https://goo.gl/pxgrxw

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?